ATE7598T1 - Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide. - Google Patents

Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.

Info

Publication number
ATE7598T1
ATE7598T1 AT79301858T AT79301858T ATE7598T1 AT E7598 T1 ATE7598 T1 AT E7598T1 AT 79301858 T AT79301858 T AT 79301858T AT 79301858 T AT79301858 T AT 79301858T AT E7598 T1 ATE7598 T1 AT E7598T1
Authority
AT
Austria
Prior art keywords
halogenated lower
compounds
alkoxycarbonylaminobenzimidazoles
parasiticides
halogen
Prior art date
Application number
AT79301858T
Other languages
English (en)
Inventor
Helmut Mrozik
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE7598T1 publication Critical patent/ATE7598T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2635Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving a phosphorus compound, e.g. Wittig synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • C07D235/32Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT79301858T 1978-09-13 1979-09-10 Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide. ATE7598T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/941,997 US4174400A (en) 1978-09-13 1978-09-13 Anthelmintic benzimidazoles
EP79301858A EP0009361B1 (de) 1978-09-13 1979-09-10 Einen Halogen enthaltenden Substituenten umfassende 2-Alkoxycarbonylaminobenzimidazole, ihre Herstellung und ihre Verwendung als Parasitizide

Publications (1)

Publication Number Publication Date
ATE7598T1 true ATE7598T1 (de) 1984-06-15

Family

ID=25477431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79301858T ATE7598T1 (de) 1978-09-13 1979-09-10 Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.

Country Status (8)

Country Link
US (1) US4174400A (de)
EP (1) EP0009361B1 (de)
JP (1) JPS5540681A (de)
AT (1) ATE7598T1 (de)
AU (1) AU534087B2 (de)
DE (1) DE2967005D1 (de)
DK (1) DK380279A (de)
ZA (1) ZA794850B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845537A1 (de) * 1978-10-19 1980-04-30 Bayer Ag Benzimidazolylcarbamidsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS58174607A (ja) * 1982-04-02 1983-10-13 トスカ紳士服株式会社 縫成品の製造法
IL78703A (en) * 1985-05-10 1993-02-21 Benzon Alfred Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials
US5922913A (en) * 1998-11-06 1999-07-13 Srm Chemical, Ltd., Co. Process for nitrating aromatic amines
ES2331250T3 (es) 2000-12-15 2009-12-28 Vertex Pharmaceuticals Incorporated Inhibidores de la girasa bacteriana y usos de los mismos.
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7582641B2 (en) * 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8193352B2 (en) * 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7618974B2 (en) * 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US20060004090A1 (en) * 2004-07-01 2006-01-05 Roberts William J Forskolin compositions and methods for administration
US20130303782A1 (en) * 2010-11-24 2013-11-14 Sequent Scientific Limited Process for preparation of albendazole
WO2012097269A1 (en) 2011-01-14 2012-07-19 Vertex Pharmaceuticals Incorporated Pyrimidine gyrase and topoisomerase iv inhibitors
ES2526902T3 (es) 2011-01-14 2015-01-16 Vertex Pharmaceuticals Incorporated Procesos de producción de inhibidores de la girasa y topoisomerasa IV
CA2824403C (en) 2011-01-14 2019-09-24 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
SG191924A1 (en) 2011-01-14 2013-08-30 Vertex Pharma Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
JP5977344B2 (ja) 2011-06-20 2016-08-24 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated ジャイレースおよびトポイソメラーゼ阻害剤のリン酸エステル
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
AR093226A1 (es) 2012-07-18 2015-05-27 Vertex Pharma Formas solidas de dihidrogeno fosfato de (r)-2-(5-(2-(3-etilureido)-6-fluoro-7-(tetrahidrofuran-2-il)-1h-benzo[d]imidazol-5-il)pirimidin-2-il)propan-2-ilo y sus sales

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE666795A (de) * 1964-08-04 1966-01-13
US3929824A (en) * 1972-12-29 1975-12-30 Syntex Inc 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3929821A (en) * 1972-12-29 1975-12-30 Syntex Inc 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives
DE2332398A1 (de) * 1973-06-26 1975-01-23 Hoechst Ag 2-carbalkoxy-amino-benzimidazol-5(6)phenylaether, ihre herstellung und verwendung in mitteln gegen helminthen
US3929823A (en) * 1973-11-21 1975-12-30 Syntex Inc 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3993768A (en) * 1974-11-25 1976-11-23 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
IT1076022B (it) * 1977-04-20 1985-04-22 Montedison Spa Benzimidazolcarbammati antielmintici

Also Published As

Publication number Publication date
EP0009361A1 (de) 1980-04-02
DK380279A (da) 1980-03-14
EP0009361B1 (de) 1984-05-23
JPS5540681A (en) 1980-03-22
AU534087B2 (en) 1984-01-05
DE2967005D1 (en) 1984-06-28
ZA794850B (en) 1981-04-29
US4174400A (en) 1979-11-13
AU5060779A (en) 1980-03-20

Similar Documents

Publication Publication Date Title
ATE7598T1 (de) Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.
DK0436680T3 (da) Heterocycliske forbindelser
KR890701566A (ko) 헤테로사이클릭 화합물
FI931708A (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK0718293T3 (da) Cyclodepsipeptidforbindelse
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
ES8801642A1 (es) Un procedimiento para la preparacion de l,2,4-triazoles
DE69613710D1 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
FI881404A0 (fi) Framstaellning av 4-/4-/4-/4-//2-(2,4 -difluorfenyl)-2-(1h-azolylmetyl)-1,3-dioxolan-4-yl/metoxi/fenyl/ -1-piperazinyl/fenyl/triazoloner.
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
DE59008356D1 (de) Heterocyclische Verbindungen.
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
IL60567A (en) 2-dihalomethylene-3-halo-3-carbalk-oxy-5-oxopyrrolidines,process for their manufacture and their use as fungicidal,bactericidal and algicidal compositions
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
NZ220772A (en) 1-hydroxypyrazole derivatives and microbicidal compositions
JPS5716841A (en) Novel compound,manufacture,bactericidal composition and use
DE69112070D1 (de) Anthelmintische und coccidizide 3-carbamoyl-4-hydroxycumarine, ihre verwendung und zusammensetzungen.
SE8005784L (sv) Heterocykliska foreningar
DE69912193D1 (de) Substituierte 2-Hydroxybenzophenone, ihre Herstellung, ihre Verwendung als fungizide und ihre fungizide Zusammensetzungen
DE69002340D1 (de) Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung.
ATE9899T1 (de) Pyridinderivate, ihre herstellung und verwendung.